D. E. Shaw & Co., Inc. Exact Sciences Corp Call Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$42.43 - $70.83 $2.38 Million - $3.98 Million	-56,200 Reduced 89.49%	6,600 $449,000
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $2.6 Million - $4.66 Million	62,800 New	62,800 $2.65 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $943,800 - $1.42 Million	-20,000 Reduced 66.67%	10,000 $678,000
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $115,092 - $177,732	-3,600 Reduced 10.71%	30,000 $975,000
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $3.57 Million - $7.64 Million	-100,200 Reduced 74.89%	33,600 $1.32 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $6.55 Million - $9.39 Million	113,800 Added 569.0%	133,800 $9.36 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $902,400 - $1.24 Million	10,000 Added 100.0%	20,000 $1.91 Million
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $1.06 Million - $1.57 Million	-11,300 Reduced 53.05%	10,000 $1.24 Million
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $976,178 - $1.39 Million	-9,800 Reduced 31.51%	21,300 $2.82 Million
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $298,972 - $418,241	-4,100 Reduced 11.65%	31,100 $3.17 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $774,925 - $1.29 Million	13,900 Added 65.26%	35,200 $3.06 Million
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $1.91 Million - $5.25 Million	-50,300 Reduced 70.25%	21,300 $1.24 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $823,196 - $1.06 Million	-10,600 Reduced 12.9%	71,600 $6.62 Million
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $894,663 - $1.21 Million	-9,900 Reduced 10.75%	82,200 $7.43 Million
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $1.79 Million - $2.36 Million	20,000 Added 27.74%	92,100 $10.9 Million
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $4.21 Million - $6.55 Million	-67,900 Reduced 48.5%	72,100 $6.25 Million
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $582,816 - $859,664	10,400 Added 8.02%	140,000 $8.83 Million
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $1.21 Million - $2.01 Million	25,000 Added 23.9%	129,600 $10.2 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $189,200 - $349,799	5,000 Added 5.02%	104,600 $6.25 Million
Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $2.41 Million - $3.47 Million	-60,400 Reduced 37.75%	99,600 $4.02 Million
Q4 2017 Feb 14, 2018	BUY	$46.49 - $60.51 $1.3 Million - $1.69 Million	27,900 Added 21.12%	160,000 $8.41 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $4.89 Million - $6.22 Million	132,100	132,100 $6.23 Million

Others Institutions Holding EXAS

# of Institutions

672

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.1 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$977 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$884 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$744 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$412 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.9B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account